MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS
海洋天然产品作为抗血管生成和抗侵袭剂
基本信息
- 批准号:7719997
- 负责人:
- 金额:$ 12.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-05-01 至 2009-04-30
- 项目状态:已结题
- 来源:
- 关键词:Biological FactorsCallyspongiaCause of DeathClassComputer Retrieval of Information on Scientific Projects DatabaseEvaluationFundingFutureGoalsGrantHydantoinsInstitutionInvasiveMalignant NeoplasmsMarinesPoriferaRed SeaResearchResearch PersonnelResourcesSourceUnited States National Institutes of Healthanaloganticancer activitycomputational chemistrycoralmarine natural productmicroorganismmodel designmolecular modelingnovelpre-clinicalprototypescaffold
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Cancer remains one of the major global causes of death. Marine natural products are enormous resource of highly bioactive compounds. The ultimate goal of this study is to discover and optimize prototype anticancer leads of marine origin. Our research is focused on four different classes of readily available marine natural products. These compounds occur in the Red Sea marine sponges Negombata magnifica, Callyspongia siphonella, Hemimycale arabica, and the soft coral Sarcophyton glaucum. We hypothesized that effective prototypic anticancer latrunculins, sipholanes, hydantoins, and cembranoids can be generated using biocatalysis and semisynthetic approaches. We also hypothesized symbiotic microorganisms associated with the Red Sea sponges N. magnifica and C. siphonella as novel biocatalysts appropriate to enhance the anticancer activity of natural product scaffolds.
The specific aims of this study were: 1) optimization of latrunculins, sipholanes, hydantoins, and cembranoids using biocatalytic and rational semisynthetic approaches; 2) application of symbiotic microorganisms associated with N. magnifica, and C. siphonella as potential biocatalysts for bioactive scaffolds; 3) application of computational chemistry and molecular modeling for the design of active semisynthetic analogs; and 4) evaluation of anti-metastatic/anti-invasive activities of the isolated compounds. These compounds showed anti-invasive, anti-migratory, antiproliferative, and HIF-1 inhibitory activities. Future efforts will be focused on preclinical evaluation of few these compounds as potential anti-invasive leads.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
癌症仍然是全球主要的死亡原因之一。海洋天然产物是具有高生物活性化合物的巨大资源。本研究的最终目标是发现和优化原型抗癌线索的海洋来源。我们的研究重点是四种不同类别的现成海洋天然产品。这些化合物存在于红海海绵Negombata magnifica、Callypongia siphonella、阿拉伯半菌藻和软珊瑚Sarcophyton glaucum中。我们假设,有效的原型抗癌latrunculins,sipholanes,乙内酰脲,西松烷,可以使用生物催化和半合成的方法产生。我们还假设了与红海海绵N. magnifica和C.作为新的生物催化剂,适合于提高天然产物支架的抗癌活性。
本研究的具体目标是:1)利用生物催化和合理半合成方法优化latrunculins、sipholanes、hetoins和cesbranoids; magnifica和C.作为生物活性支架的潜在生物催化剂; 3)应用计算化学和分子模拟设计活性半合成类似物;和4)评价分离的化合物的抗转移/抗侵袭活性。这些化合物显示出抗侵袭、抗迁移、抗增殖和HIF-1抑制活性。未来的努力将集中在临床前评估的几个这些化合物作为潜在的抗侵入性的领导。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KHALID A EL SAYED其他文献
KHALID A EL SAYED的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KHALID A EL SAYED', 18)}}的其他基金
Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression
靶向 PCSK9 轴抑制去势抵抗性前列腺癌复发
- 批准号:
10555260 - 财政年份:2022
- 资助金额:
$ 12.41万 - 项目类别:
Targeting PCSK9 axis for castration-resistant prostate cancer recurrence suppression
靶向 PCSK9 轴抑制去势抵抗性前列腺癌复发
- 批准号:
10429627 - 财政年份:2022
- 资助金额:
$ 12.41万 - 项目类别:
Oleocanthal functional food products for breast cancer recurrence control
用于控制乳腺癌复发的油橄榄功能性食品
- 批准号:
10276305 - 财政年份:2020
- 资助金额:
$ 12.41万 - 项目类别:
Design of novel c-Met inhibitors inspired by olive phenolics
受橄榄酚类启发的新型 c-Met 抑制剂的设计
- 批准号:
8434417 - 财政年份:2013
- 资助金额:
$ 12.41万 - 项目类别:
MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS
海洋天然产品作为抗血管生成和抗侵袭剂
- 批准号:
7959461 - 财政年份:2009
- 资助金额:
$ 12.41万 - 项目类别:
MARINE NATURAL PRODUCTS AS ANTI-ANGIOGENIC AND ANTI-INVASIVE AGENTS
海洋天然产品作为抗血管生成和抗侵袭剂
- 批准号:
7609940 - 财政年份:2007
- 资助金额:
$ 12.41万 - 项目类别:
DEVELOPMENT OF MARINE MACROLIDES LATRUNCULINS AS ANGIOGENESIS MODULATORS
作为血管生成调节剂的海洋大环内酯 Latrunculins 的开发
- 批准号:
7381335 - 财政年份:2006
- 资助金额:
$ 12.41万 - 项目类别:
ANTICANCER AND ANTI-INFECTIVE METABILITES FOR SYMBIOTIC MARINE MICROORGANISMS
共生海洋微生物的抗癌和抗感染代谢物
- 批准号:
7381336 - 财政年份:2006
- 资助金额:
$ 12.41万 - 项目类别:
DEVELOPMENT OF THE MARINE MACROLIDES LATRUNCULINS
海洋大环内酯类 LATRUNCULINS 的开发
- 批准号:
6981539 - 财政年份:2003
- 资助金额:
$ 12.41万 - 项目类别:














{{item.name}}会员




